Infective Endocarditis (IE)
10
0
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis
The Study Tests if Preoperative Dental Screening is Superior to no Preoperative Dental Screening in Improving the Outcome of Patients Undergoing Surgical Cardiac Valve Replacement or Transcatheter Cardiac Valve Implantation.
Outcomes of Surgical Treatment in Patients With Infective Endocarditis
Anemia Therapy in Patients With Infective Endocarditis
From Commensalism to Pathogenicity: Exploring the Pathophysiology of Bacteremia to Better Understand Enterococcus Faecalis Infective Endocarditis
Inflammation and Infective Endocarditis
European Research Group on Outcomes of Surgical Treatment of Infective Endocarditis
Electronic Archive of Patients With Congenital Heart Disease and Diagnosis of Infective Endocarditis
Etiology of Endocarditis in Negative Blood Cultures
Impact of Clinical Care Pathway on Prognosis and Therapeutic Medical Care of Infective Endocarditis